234 related articles for article (PubMed ID: 34646118)
1. Acute Hepatic Porphyria: Pathophysiological Basis of Neuromuscular Manifestations.
de Souza PVS; Badia BML; Farias IB; Pinto WBVR; Oliveira ASB
Front Neurosci; 2021; 15():715523. PubMed ID: 34646118
[TBL] [Abstract][Full Text] [Related]
2. Acute hepatic porphyrias for the neurologist: current concepts and perspectives.
Souza PVS; Badia BML; Farias IB; Gonçalves EA; Pinto WBVR; Oliveira ASB
Arq Neuropsiquiatr; 2021 Jan; 79(1):68-80. PubMed ID: 33656101
[TBL] [Abstract][Full Text] [Related]
3. Givosiran to treat acute porphyria.
Honor A; Rudnick SR; Bonkovsky HL
Drugs Today (Barc); 2021 Jan; 57(1):47-59. PubMed ID: 33594389
[TBL] [Abstract][Full Text] [Related]
4. Hepatic porphyria: A narrative review.
Arora S; Young S; Kodali S; Singal AK
Indian J Gastroenterol; 2016 Nov; 35(6):405-418. PubMed ID: 27796941
[TBL] [Abstract][Full Text] [Related]
5. Drugs and acute porphyrias: reasons for a hazardous relationship.
Roveri G; Nascimbeni F; Rocchi E; Ventura P
Postgrad Med; 2014 Nov; 126(7):108-20. PubMed ID: 25387219
[TBL] [Abstract][Full Text] [Related]
6. Role of delta-aminolevulinic acid in the symptoms of acute porphyria.
Bissell DM; Lai JC; Meister RK; Blanc PD
Am J Med; 2015 Mar; 128(3):313-7. PubMed ID: 25446301
[TBL] [Abstract][Full Text] [Related]
7. A family with acute intermittent porphyria.
Billoo AG; Lone SW
J Coll Physicians Surg Pak; 2008 May; 18(5):316-8. PubMed ID: 18541093
[TBL] [Abstract][Full Text] [Related]
8. Acute hepatic and erythropoietic porphyrias: from ALA synthases 1 and 2 to new molecular bases and treatments.
Manceau H; Gouya L; Puy H
Curr Opin Hematol; 2017 May; 24(3):198-207. PubMed ID: 28118224
[TBL] [Abstract][Full Text] [Related]
9. Porphyria: What Is It and Who Should Be Evaluated?
Edel Y; Mamet R
Rambam Maimonides Med J; 2018 Apr; 9(2):. PubMed ID: 29553924
[TBL] [Abstract][Full Text] [Related]
10. Acute hepatic porphyrias: Identification of 46 hydroxymethylbilane synthase, 11 coproporphyrinogen oxidase, and 20 protoporphyrinogen oxidase novel mutations.
Loskove Y; Yasuda M; Chen B; Nazarenko I; Cody N; Desnick RJ
Mol Genet Metab; 2019 Nov; 128(3):352-357. PubMed ID: 30385147
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietic and hepatic porphyrias.
Gross U; Hoffmann GF; Doss MO
J Inherit Metab Dis; 2000 Nov; 23(7):641-61. PubMed ID: 11117426
[TBL] [Abstract][Full Text] [Related]
12. The acute hepatic porphyrias: current status and future challenges.
Siegesmund M; van Tuyll van Serooskerken AM; Poblete-Gutiérrez P; Frank J
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):593-605. PubMed ID: 20955962
[TBL] [Abstract][Full Text] [Related]
13. Clinical Guide and Update on Porphyrias.
Stölzel U; Doss MO; Schuppan D
Gastroenterology; 2019 Aug; 157(2):365-381.e4. PubMed ID: 31085196
[TBL] [Abstract][Full Text] [Related]
14. Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver.
Schmitt C; Lenglet H; Yu A; Delaby C; Benecke A; Lefebvre T; Letteron P; Paradis V; Wahlin S; Sandberg S; Harper P; Sardh E; Sandvik AK; Hov JR; Aarsand AK; Chiche L; Bazille C; Scoazec JY; To-Figueras J; Carrascal M; Abian J; Mirmiran A; Karim Z; Deybach JC; Puy H; Peoc'h K; Manceau H; Gouya L
J Intern Med; 2018 Jul; 284(1):78-91. PubMed ID: 29498764
[TBL] [Abstract][Full Text] [Related]
15. The acute hepatic porphyrias.
Wang B
Transl Gastroenterol Hepatol; 2021; 6():24. PubMed ID: 33824928
[TBL] [Abstract][Full Text] [Related]
16. Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.
Balwani M; Sardh E; Ventura P; Peiró PA; Rees DC; Stölzel U; Bissell DM; Bonkovsky HL; Windyga J; Anderson KE; Parker C; Silver SM; Keel SB; Wang JD; Stein PE; Harper P; Vassiliou D; Wang B; Phillips J; Ivanova A; Langendonk JG; Kauppinen R; Minder E; Horie Y; Penz C; Chen J; Liu S; Ko JJ; Sweetser MT; Garg P; Vaishnaw A; Kim JB; Simon AR; Gouya L;
N Engl J Med; 2020 Jun; 382(24):2289-2301. PubMed ID: 32521132
[TBL] [Abstract][Full Text] [Related]
17. Porphyrias: A 2015 update.
Karim Z; Lyoumi S; Nicolas G; Deybach JC; Gouya L; Puy H
Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):412-25. PubMed ID: 26142871
[TBL] [Abstract][Full Text] [Related]
18. Acute intermittent porphyria--impact of mutations found in the hydroxymethylbilane synthase gene on biochemical and enzymatic protein properties.
Ulbrichova D; Hrdinka M; Saudek V; Martasek P
FEBS J; 2009 Apr; 276(7):2106-15. PubMed ID: 19292878
[TBL] [Abstract][Full Text] [Related]
19. Acute Porphyrias.
Besur S; Schmeltzer P; Bonkovsky HL
J Emerg Med; 2015 Sep; 49(3):305-12. PubMed ID: 26159905
[TBL] [Abstract][Full Text] [Related]
20. Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria.
Sardh E; Harper P; Balwani M; Stein P; Rees D; Bissell DM; Desnick R; Parker C; Phillips J; Bonkovsky HL; Vassiliou D; Penz C; Chan-Daniels A; He Q; Querbes W; Fitzgerald K; Kim JB; Garg P; Vaishnaw A; Simon AR; Anderson KE
N Engl J Med; 2019 Feb; 380(6):549-558. PubMed ID: 30726693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
